• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中拷贝数改变的临床、生物学和治疗影响的见解。

Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer.

机构信息

Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA 6009, Australia.

Curtin Medical School, Curtin University, Perth, WA 6102, Australia.

出版信息

Int J Mol Sci. 2024 Jun 21;25(13):6815. doi: 10.3390/ijms25136815.

DOI:10.3390/ijms25136815
PMID:38999925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11241182/
Abstract

Copy number alterations (CNAs), resulting from the gain or loss of genetic material from as little as 50 base pairs or as big as entire chromosome(s), have been associated with many congenital diseases, de novo syndromes and cancer. It is established that CNAs disturb the dosage of genomic regions including enhancers/promoters, long non-coding RNA and gene(s) among others, ultimately leading to an altered balance of key cellular functions. In cancer, CNAs have been associated with almost all steps of the disease: predisposition, initiation, development, maintenance, response to treatment, resistance, and relapse. Therefore, understanding how specific CNAs contribute to tumourigenesis may provide prognostic insight and ultimately lead to the development of new therapeutic approaches to improve patient outcomes. In this review, we provide a snapshot of what is currently known about CNAs and cancer, incorporating topics regarding their detection, clinical impact, origin, and nature, and discuss the integration of innovative genetic engineering strategies, to highlight the potential for targeting CNAs using novel, dosage-sensitive and less toxic therapies for CNA-driven cancer.

摘要

拷贝数改变(CNAs),源自于从少至 50 个碱基对至整个染色体(s)的遗传物质的增益或损失,与许多先天性疾病、新生综合征和癌症有关。已证实 CNAs 扰乱了基因组区域的剂量,包括增强子/启动子、长非编码 RNA 和基因(s)等,最终导致关键细胞功能的失衡。在癌症中,CNAs 与疾病的几乎所有步骤都有关:易感性、起始、发展、维持、对治疗的反应、耐药性和复发。因此,了解特定的 CNAs 如何促进肿瘤发生可能提供预后见解,并最终导致开发新的治疗方法来改善患者的预后。在这篇综述中,我们提供了目前关于 CNAs 和癌症的一些信息,包括关于它们的检测、临床影响、起源和性质的主题,并讨论了创新的基因工程策略的整合,以突出使用新型、剂量敏感和毒性较小的疗法针对 CNA 驱动的癌症的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ea/11241182/f00b863f7c8a/ijms-25-06815-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ea/11241182/c4d7c2e4f3d7/ijms-25-06815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ea/11241182/0b6440444e5f/ijms-25-06815-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ea/11241182/f00b863f7c8a/ijms-25-06815-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ea/11241182/c4d7c2e4f3d7/ijms-25-06815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ea/11241182/0b6440444e5f/ijms-25-06815-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ea/11241182/f00b863f7c8a/ijms-25-06815-g003.jpg

相似文献

1
Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer.癌症中拷贝数改变的临床、生物学和治疗影响的见解。
Int J Mol Sci. 2024 Jun 21;25(13):6815. doi: 10.3390/ijms25136815.
2
CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.CNApp,一种用于拷贝数改变定量分析和综合分析揭示临床意义的工具。
Elife. 2020 Jan 15;9:e50267. doi: 10.7554/eLife.50267.
3
Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes.在低覆盖度癌症基因组中进行大规模和焦点拷贝数改变的层次式发现。
BMC Bioinformatics. 2020 Apr 16;21(1):147. doi: 10.1186/s12859-020-3480-3.
4
Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.巴西患者肾透明细胞癌中的体细胞拷贝数改变及相关基因
Int J Mol Sci. 2021 Feb 25;22(5):2265. doi: 10.3390/ijms22052265.
5
Replication stress generates distinctive landscapes of DNA copy number alterations and chromosome scale losses.复制压力会产生独特的 DNA 拷贝数改变和染色体尺度丢失景观。
Genome Biol. 2022 Oct 20;23(1):223. doi: 10.1186/s13059-022-02781-0.
6
Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer.基因组拷贝数改变作为三阴性妊娠相关性乳腺癌的生物标志物。
Cell Oncol (Dordr). 2022 Aug;45(4):591-600. doi: 10.1007/s13402-022-00685-6. Epub 2022 Jul 6.
7
Prognostic Values of Gene Copy Number Alterations in Prostate Cancer.前列腺癌中基因拷贝数改变的预后价值。
Genes (Basel). 2023 Apr 22;14(5):956. doi: 10.3390/genes14050956.
8
The shaping and functional consequences of the dosage effect landscape in multiple myeloma.多发性骨髓瘤中剂量效应景观的形成及其功能后果。
BMC Genomics. 2013 Oct 2;14:672. doi: 10.1186/1471-2164-14-672.
9
Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients.乳腺癌患者未受累乳腺组织中与基因组稳定性维持相关基因的DNA拷贝数改变与突变并存
Hum Mutat. 2015 Nov;36(11):1088-99. doi: 10.1002/humu.22845. Epub 2015 Aug 14.
10
Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.程序性死亡配体1(PD-L1,CD274)拷贝数变化的泛癌分析——与基因表达、突变负荷及生存的关联
Genes Chromosomes Cancer. 2016 Aug;55(8):626-39. doi: 10.1002/gcc.22365. Epub 2016 May 30.

引用本文的文献

1
Genetic background and oncogenic driver determines the genomic evolution and transcriptomics of mammary tumor metastasis.遗传背景和致癌驱动因素决定了乳腺肿瘤转移的基因组进化和转录组学。
Commun Biol. 2025 Aug 14;8(1):1224. doi: 10.1038/s42003-025-08624-5.
2
The Histomorphology to Molecular Transition: Exploring the Genomic Landscape of Poorly Differentiated Epithelial Endometrial Cancers.从组织形态学到分子转变:探索低分化子宫内膜上皮癌的基因组格局
Cells. 2025 Mar 5;14(5):382. doi: 10.3390/cells14050382.
3
Replication stress increases de novo CNVs across the malaria parasite genome.

本文引用的文献

1
Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia.DYRK1A抑制剂在唐氏综合征急性淋巴细胞白血病新模型中的疗效
Haematologica. 2024 Jul 1;109(7):2309-2315. doi: 10.3324/haematol.2023.284271.
2
HER2-targeted therapies in cancer: a systematic review.癌症中的HER2靶向治疗:一项系统评价。
Biomark Res. 2024 Feb 2;12(1):16. doi: 10.1186/s40364-024-00565-1.
3
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression.非整倍体急性淋巴细胞白血病中的染色体不稳定性与疾病进展相关。
复制应激增加了疟原虫基因组中的新生拷贝数变异。
bioRxiv. 2024 Dec 31:2024.12.19.629492. doi: 10.1101/2024.12.19.629492.
EMBO Mol Med. 2024 Jan;16(1):64-92. doi: 10.1038/s44321-023-00006-w. Epub 2023 Dec 15.
4
A framework for the clinical implementation of optical genome mapping in hematologic malignancies.光学基因组图谱分析在血液系统恶性肿瘤中临床应用的框架。
Am J Hematol. 2024 Apr;99(4):642-661. doi: 10.1002/ajh.27175. Epub 2024 Jan 2.
5
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.唐氏综合征患儿、青少年和青年急性淋巴细胞白血病患者的结局:儿童肿瘤协作组的报告。
J Clin Oncol. 2024 Jan 10;42(2):218-227. doi: 10.1200/JCO.23.00389. Epub 2023 Oct 27.
6
Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALL.儿童急性淋巴细胞白血病中超二倍体的预后和药代动力学异质性。
J Clin Oncol. 2023 Dec 10;41(35):5422-5432. doi: 10.1200/JCO.23.00880. Epub 2023 Sep 20.
7
Down syndrome and leukemia: from basic mechanisms to clinical advances.唐氏综合征与白血病:从基础机制到临床进展。
Haematologica. 2023 Oct 1;108(10):2570-2581. doi: 10.3324/haematol.2023.283225.
8
Oncogene-like addiction to aneuploidy in human cancers.人类癌症中类似癌基因的非整倍体成瘾。
Science. 2023 Aug 25;381(6660):eadg4521. doi: 10.1126/science.adg4521.
9
Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review.普拉德-威利综合征中的恶性肿瘤:来自大型国际队列研究和文献回顾的结果。
J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1720-e1730. doi: 10.1210/clinem/dgad312.
10
Prognostic Values of Gene Copy Number Alterations in Prostate Cancer.前列腺癌中基因拷贝数改变的预后价值。
Genes (Basel). 2023 Apr 22;14(5):956. doi: 10.3390/genes14050956.